Vaccines

11 Feb 2020 Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates
10 Feb 2020 Inovio receives authorization from U.S. FDA to begin Phase 1/2 trial for INO-3107 to treat RRP
10 Feb 2020 Clover Successfully Produced 2019-nCoV Subunit Vaccine Candidate and Detected Cross-Reacting Antibodies from Sera of Multiple Infected Patients
08 Feb 2020 Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV
08 Feb 2020 Immunicum AB (publ) Presents Updated Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer at ASCO-SITC Clinical Immuno-Oncology Symposium
07 Feb 2020 Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
06 Feb 2020 Generex Biotechnology Subsidiaries NuGenerex Immuno-Oncology and NuGenerex Diagnostics Working to Address the Coronavirus Pandemic and Emerging Risk of Avian Flu Using Ii-Key Peptide Vaccines
03 Feb 2020 HIV Vaccine Trial HVTN 702 Stopped Early for Non-Efficacy; Other Vaccine Trials Not Affected; AVAC Calls for Ongoing Support to Vaccine Research
03 Feb 2020 Seqirus Announces U.S. FDA Approval of Its First-Ever Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine
03 Feb 2020 CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
02 Feb 2020 Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
02 Feb 2020 CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019
02 Feb 2020 Vaxart Announces Initiation of Coronavirus Vaccine Program
02 Feb 2020 Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency
02 Feb 2020 FDA Approves Aimmune’s PALFORZIA™ as First Treatment for Peanut Allergy
30 Jan 2020 Inovio collaborating with Beijing Advaccine to advance INO-4800 vaccine against new coronavirus in China
30 Jan 2020 Tonix Pharmaceuticals Presented Results from a Preclinical Study of TNX-801, a Potential Vaccine to Prevent Smallpox and Monkeypox, in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference
30 Jan 2020 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial
28 Jan 2020 Researchers Present Positive Interim Data on Appili Therapeutics’ ATI-1701 Biodefense Program at 2020 ASM Biothreats
28 Jan 2020 Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV)
28 Jan 2020 GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development
27 Jan 2020 GeoVax and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine
23 Jan 2020 Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
23 Jan 2020 Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
23 Jan 2020 CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top